Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer
Clinical trial NCT05843188 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05843188
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-09
- Primary completion
- 2026-12-24
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.